These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33870225)

  • 1. Optimized CRISPR/Cas9-mediated single nucleotide mutation in adherent cancer cell lines.
    Gao P; Dong X; Wang Y; Wei GH
    STAR Protoc; 2021 Jun; 2(2):100419. PubMed ID: 33870225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimized protocol to create deletion in adherent cell lines using CRISPR/Cas9 system.
    Farooq U; Notani D
    STAR Protoc; 2021 Dec; 2(4):100857. PubMed ID: 34746853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-Cas9-Based Genome Editing and Cytidine Base Editing in
    Wang Y; Wang Z; Ji Q
    STAR Protoc; 2020 Jun; 1(1):100025. PubMed ID: 33111078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimized protocol for gene editing in adipocytes using CRISPR-Cas9 technology.
    Qiu Y; Ding Q
    STAR Protoc; 2021 Mar; 2(1):100307. PubMed ID: 33554142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Cas9-mediated induction of large chromosomal inversions in human bronchial epithelial cells.
    Angelopoulou A; Papaspyropoulos A; Papantonis A; Gorgoulis VG
    STAR Protoc; 2022 Jun; 3(2):101257. PubMed ID: 35330963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimized protocols for efficient gene editing in mouse hepatocytes
    Chen Y; Ding Q
    STAR Protoc; 2022 Mar; 3(1):101062. PubMed ID: 35005644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol for editing fibroblasts with in vitro transcribed Cas9 mRNA and profile off-target editing by optimized GUIDE-seq.
    Li Z; Reint G; Haapaniemi EM
    STAR Protoc; 2023 Dec; 4(4):102662. PubMed ID: 37889758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical-genetic CRISPR-Cas9 screens in human cells using a pathway-specific library.
    Hundley FV; Toczyski DP
    STAR Protoc; 2021 Sep; 2(3):100685. PubMed ID: 34382013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized electroporation of CRISPR-Cas9/gRNA ribonucleoprotein complex for selection-free homologous recombination in human pluripotent stem cells.
    Xu H; Kita Y; Bang U; Gee P; Hotta A
    STAR Protoc; 2021 Dec; 2(4):100965. PubMed ID: 34825222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR-Cas9 Ribonucleoprotein-Mediated Genomic Editing in Primary Innate Immune Cells.
    Hildreth AD; Riggan L; O'Sullivan TE
    STAR Protoc; 2020 Dec; 1(3):100113. PubMed ID: 33377009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A user-friendly and streamlined protocol for CRISPR/Cas9 genome editing in budding yeast.
    Novarina D; Koutsoumpa A; Milias-Argeitis A
    STAR Protoc; 2022 Jun; 3(2):101358. PubMed ID: 35712010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A protocol for efficient CRISPR-Cas9-mediated knock-in in colorectal cancer patient-derived organoids.
    Okamoto T; Natsume Y; Yamanaka H; Fukuda M; Yao R
    STAR Protoc; 2021 Dec; 2(4):100780. PubMed ID: 34585151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol for establishing knockout cell clones by deletion of a large gene fragment using CRISPR-Cas9 with multiple guide RNAs.
    Saito AC; Higashi T; Chiba H
    STAR Protoc; 2024 Sep; 5(3):103179. PubMed ID: 38972040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocol for arrayed gRNA screening by base editors in mammalian cell lines using lentiviral system.
    Ravi NS; George A; Mohankumar KM
    STAR Protoc; 2023 Dec; 4(4):102668. PubMed ID: 37922314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient CRISPR-Cas9-mediated genome editing for characterization of essential genes in
    Picchi-Constante GFA; Hiraiwa PM; Marek M; Rogerio VZ; Guerra-Slompo EP; Romier C; Zanchin NIT
    STAR Protoc; 2022 Jun; 3(2):101324. PubMed ID: 35496799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol for the saturation and multiplexing of genetic variants using CRISPR-Cas9.
    Sahu S; Sullivan T; Southon E; Caylor D; Geh J; Sharan SK
    STAR Protoc; 2023 Dec; 4(4):102702. PubMed ID: 37948185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of CRISPR-Cas9-generated point mutant mice using MiSeq and locked nucleic acid probe PCR.
    Vasu K; Fox PL
    STAR Protoc; 2021 Dec; 2(4):100785. PubMed ID: 34585153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol for Genome Editing to Produce Multiple Mutants in Wheat.
    Abe F; Ishida Y; Hisano H; Endo M; Komari T; Toki S; Sato K
    STAR Protoc; 2020 Sep; 1(2):100053. PubMed ID: 33111098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generating mutant
    Li HH; Li JC; Su MP; Liu KL; Chen CH
    STAR Protoc; 2021 Jun; 2(2):100432. PubMed ID: 33899015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol for CRISPR-Cas9-mediated genome editing to study spermatogenesis in Caenorhabditis elegans.
    Wang P; Cao Z; Wang Q; Ma X; Wang N; Chen L; Zhao Y; Miao L
    STAR Protoc; 2023 Dec; 4(4):102720. PubMed ID: 37967017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.